Product
Ara-C
3 clinical trials
7 indications
Indication
Myelodysplastic SyndromesIndication
Acute Myeloid LeukemiaIndication
Chronic Myelomonocytic LeukemiaIndication
LeukemiaIndication
myeloidIndication
AcuteIndication
Acute Myeloid Leukemia (AML)Clinical trial
Phase-I/II Trial to Assess the Safety and Efficacy of Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML (FLAMSAClaxStatus: Recruiting, Estimated PCD: 2026-01-31
Clinical trial
Risk-adapted Therapy for Primary Acute Myeloid Leukemia (AML) in Adult Patients up to 70 Years OldStatus: Completed, Estimated PCD: 2022-07-31
Clinical trial
A Phase 2 Study of Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed AMLStatus: Withdrawn, Estimated PCD: 2026-09-30